PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-25.60%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-60.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
1.26%
Positive EBIT growth while RUN is negative. John Neff might see a substantial edge in operational management.
-2402.01%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-126.30%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-121.25%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-127.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
10.75%
Share count expansion well above RUN's 0.86%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.64%
Slight or no buyback while RUN is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-7700.65%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-934.80%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.10%
Negative 10Y revenue/share CAGR while RUN stands at 360.85%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-20.32%
Negative 5Y CAGR while RUN stands at 182.05%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
12.30%
3Y revenue/share CAGR under 50% of RUN's 76.62%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-635.26%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-23.78%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-16.38%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-106.42%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
88.32%
Positive 5Y CAGR while RUN is negative. John Neff might view this as a strong mid-term relative advantage.
99.12%
Positive short-term CAGR while RUN is negative. John Neff would see a clear advantage in near-term profit trajectory.
-99.63%
Negative equity/share CAGR over 10 years while RUN stands at 74.53%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-99.51%
Negative 5Y equity/share growth while RUN is at 87.51%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-99.06%
Negative 3Y equity/share growth while RUN is at 9.82%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
67.60%
Our AR growth while RUN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
139.77%
We show growth while RUN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-8.03%
Negative asset growth while RUN invests at 2.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-15.74%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.27%
We’re deleveraging while RUN stands at 7.27%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-14.37%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-6.94%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.